Blog
RSS FeedPosted by Michael Wonder on 06 Sep 2018
Is it time for a review of the content in PBAC Public Summary Documents?
7 September 2018 - Important content is either not reported or not reported in a consistent manner. ...
Posted by Michael Wonder on 06 Sep 2018
We can make medicine affordable without the damage Pharmacare will cause Canadians
5 September 2018 - Governments should have public plans match the superior coverage offered in private drug plans and cover more ...
Posted by Michael Wonder on 06 Sep 2018
Health insurance funds to help government sell premium hikes
6 September 2018 - Health funds will provide an unprecedented level of detail with their applications to raise premiums next ...
Posted by Michael Wonder on 06 Sep 2018
UK lags behind most of Europe in access to biologics for patients with rheumatoid arthritis
4 September 2018 - Global leader in biosimilars, Celltrion Healthcare announces support for the easing of initiation boundaries for biologics that ...
Posted by Michael Wonder on 06 Sep 2018
Proposal on the funding of infliximab, rituximab and tocilizumab
6 September 2018 - PHARMAC is proposing to change how three hospital medicines are managed within the Pharmaceutical Schedule. ...
Posted by Michael Wonder on 06 Sep 2018
Approval of multi-product funding agreement with Novartis
6 September 2018 - PHARMAC is pleased to announce a major funding package involving ten medicines in seven key therapy ...
Posted by Michael Wonder on 06 Sep 2018
New agreement makes more medicines available to treat range of health conditions
6 September 2018 - Up to 50,000 New Zealanders per year will benefit from a new multiproduct agreement PHARMAC has ...
Posted by Michael Wonder on 05 Sep 2018
Publication of final base-case ICERs (ICURs) by health technology assessment agencies
6 September 2018 - The Department of Health is dragging its heels on this issue. ...
Posted by Michael Wonder on 05 Sep 2018
Hand surgeon's career 'saved by gene-silencing drug'
5 September 2018 - Hand surgeon Carlos Heras-Palou said his career "would have been finished" in six months without the treatment. ...
Posted by Michael Wonder on 05 Sep 2018
Brad Hazzard’s call to stop free health care for tourists and visitors
6 September 2018 - All visitors to Australia will be required to have health insurance under a NSW government proposal ...
Posted by Michael Wonder on 05 Sep 2018
NICE u-turn approves funding for rare disease therapy Crysvita
5 September 2018 - NICE has changed its position on NHS funding for Kyowa Kirin International’s Crysvita, now endorsing the ...
Posted by Michael Wonder on 05 Sep 2018
Deal for NHS to offer exciting new child cancer therapy
5 September 2018 - A deal has been struck to let the NHS offer children an expensive new cancer therapy ...
Posted by Michael Wonder on 04 Sep 2018
Why aren't final base-case ICERs published in the PBAC Public Summary Documents?
5 September 2018 - The case for not doing so is now very weak. ...
Posted by Michael Wonder on 04 Sep 2018
Australian millennials are sick of paying for baby boomers' health care
5 September 2018 - Young people are quitting private health insurance in droves. ...
Posted by Michael Wonder on 04 Sep 2018
Merck gets partial thumbs-down on Keytruda in lymphoma from NICE cost-effectiveness watchdogs
4 September 2018 - NICE quibbled with Merck's methodology for demonstrating the cost effectiveness of Keytruda in treating Hodgkin lymphoma patients ...